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Abstract 
The  transgenic  animals  with  mutant  cop-
per/zinc  superoxide  dismutase  (SOD1)  DNA
develop paralytic motor neuron disease resem-
bling  human  amyotrophic  lateral  sclerosis
(ALS) patients and are commonly used as mod-
els for ALS. In the transgenic (Tg) mice with
the G93A mutation of the human SOD1 gene
(SOD1G93A mice), the loss of ventral root axons
and the synapses between the muscles and the
motor neurons suggested that the motor neu-
ron  degeneration  might  proceed  in  a  dying-
back degeneration pattern. To reveal the rela-
tionship between axonal degeneration and the
progression  of  the  muscle  atrophy  in  the
SOD1G93A mice, we investigated the status of the
neuromuscular junction along the disease pro-
gression.  As  a  presynaptic  or  postsynaptic
marker  of  neuromuscular  junction  (NMJ),
anti-synaptic vesicle protein 2 (anti-SV2) anti-
body and α-bungarotoxin (α-BuTX ) were cho-
sen in this study and, as a marker of synaptic
cleft, anti-agrin antibody was chosen in this
study.  In  the  immunohistochemistry  of  α-
BuTX and anti-SV2 antibody, the percentages
of double positive NMJs among α-BuTX single
positive were decreased in Tg mice through
time from ten weeks. The number of postsy-
naptic acethylcholine receptor (AChR) clusters
did not decrease in Tg mice even at the end
stage. Immunohistochemistry of α-BuTX and
anti-agrin antibody revealed that the increase
of immunopositive area of anti-agrin antibody
around the muscle fiber in Tg mice from ten
weeks of age. In this study, we revealed that
the detachment of nerve terminals started at
ten weeks in Tg mice. The levels of AChR did
not change throughout 5-20 weeks of age in
both groups of mice, and AChR remains clus-
tering  at  NMJs,  suggesting  that  the  muscle
abnormality  is  the  result  of  detachment  of
nerve terminals.  
Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal
neurodegenerative disease, typically leading to
paralysis, respiratory failure and death within
3-5 years after onset. Most patients are spo-
radic, but about 20% of familial ALS patients
have the mutation in the copper/zinc superox-
ide dismutase (SOD1) gene, and more than
100 mutations have been reported.
1,2The trans-
genic animals with mutant SOD1 DNA develop
paralytic  motor  neuron  disease  resembling
human ALS patients and are commonly used
as models for ALS.
3-6
Transgenic (Tg) mice with the G93A muta-
tion of the human SOD1 gene (SOD1G93A mice)
were the first established model
4 and the most
widely studied,
7 so many trials for treatment
have used this animal model. The mice showed
first clinical signs as a tremor at 80-90 days
after birth, gradually developed paralysis, and
died at 140-150 days. In the anterior horn of
the spinal cord, the first histological abnormal-
ity was mitochondria swelling in motor neuron
at 60 days as a consequence of the abnormal
stability.
8,9 Then  astrocytosis  was  revealed
around  80  days.  Lastly  motor  neuron  loss
became prominent from 100 days, when the
clinical symptoms were already observed. The
axonal  transport  defects  were  found  as  the
early events of motor neuron disease,
10-12 and
the inhibition of retrograde axonal transport
by overexpression of dynamitin demonstrated
motor  neuron  degeneration.
13 Moreover,  the
loss  of  ventral  root  axons  and  the  synapses
between the muscles and the motor neurons
suggested that the motor neuron degeneration
might proceed in a dying-back degeneration
pattern.
14,15 The  first  event  in  ALS  is  the
destruction  of  the  neuromuscular  junction
(NMJ), more specifically of the postsynaptic
apparatus,  followed  by  axonal  degeneration
and late-onset degeneration of motor neuron
cell body.
14However, recent studies have shown
that even a complete rescue of motor neuron
cell bodies does not cure mice over-expressing
mutant forms of the SOD1 enzyme (mSOD1
mice).
16-18 Hence, preserving motor neuron cell
bodies is therapeutically not sufficient since
the rescued motor neurons are unable to recre-
ate destroyed NMJs. To reveal the relationship
between axonal degeneration and the progres-
sion  of  the  muscle  atrophy  in  the  SOD1G93A
mice, we investigated the status of the NMJ
along the disease progression.  
Materials and Methods 
All experimental procedures were approved
by  the  Animal  Care  and  Use  Committee  of
Okayama University. The SOD1G93A mice were
obtained  from  Jackson  Laboratories  (B6SJL-
TgN  (SOD1-G93A)  1Gur  mice)  (Bar  Harbor,
ME) (Gurney et al., 1994), and the line was
maintained as hemizygotes by mating SOD1G93A
males  with  C57BL/6J  females.  The  offspring
were genotyped by a polymerase chain reac-
tion assay of DNA obtained from tail tissue.
They  are  the  high-expressing  G93A  SOD1
mutant mice that display disease onset at 15
weeks and die approximately four weeks later.
Since there is a difference in disease onset
between male and female SOD1G93A mice, only
males were used in this study.  
We  analyzed  disease  progressions  by  a
rotarod task every seven days. We measured
the time until mice fell from the rod or after an
arbitrary limit of 600 seconds. We performed
three trials, and recorded the average time for
every  mouse.  For  histological  studies  and
Western blot analysis, SOD1G93A mice and non-
transgenic mice were deeply anesthetized at
five, ten, 15 and 20 weeks of age (each group 
n=5),  and  transcardially  perfused  with
heparinized phosphate-buffered saline (PBS)
(pH 7.4). The right soleus muscles were frozen
for Western blot examination, and the left side
muscles were quickly frozen by liquid nitrogen
for histological studies. The right side muscles
were cut on cryostat at a thickness of 10 μm at
-20°C. Frozen transverse sections were fixed
in  4%  paraformaldehyde  for  15  min,  and
stained with hematoxylin and eosin (HE) for
morphological assessment. For immunohisto-
chemistry, the sections were incubated with
5% bovine serum albumin for one hour at room
temperature to block the non-specific binding
of antibodies. Sections were reacted with pri-
mary antibodies overnight at 4°C. The follow-
ing  primary  antibodies  were  used:  anti-SV2
(sc-11936,  Santa  Cruz  Biotechnology,  CA,
USA), anti-agrin (MAB5204, Chemicon, Teme-
cula, CA, USA), and α-bungarotoxin (BuTX)
biotin-XX-conjugate  (B-1196,  Molecular
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PBS, the sections were exposed to appropriate
secondary  antibodies  conjugated  fluorescent
dye for one hour at room temperature, then
washed with PBS again, and mounted. A set of
sections was treated without the primary anti-
body to ascertain the specific detection by the
antibodies used. Sections were examined and
photographed through a microscope (Olympus
BX 51) under epifluorescent illumination. We
evaluated the remaining neuromuscular junc-
tions (NMJs) as counting α-BuTX and SV2-
double  positive  synapses  with  a  diameter
above  20  μm.  Counting  was  performed  by
investigators blinded to the genotype. Multiple
group comparisons of the differences in quan-
titative measurements were made by Student’s
t-test. Statistical significance was accepted at
the  level  of  p<0.05.  The  protein  level  for
acethylcholine receptor (AChR) was analyzed
by SDS-PAGE and transferred to a PVDF mem-
brane  (Millipore  Corporation,  Bedford,  MA,
USA). The blots were blocked in 5% dry milk in
Tris-buffered saline for one hour at room tem-
perature. The proteins were detected by incu-
bating the blots overnight at 4°C with the first
primary antibodies, followed by HRP-conjugat-
ed secondary antibody (GE Healthcare Bio-sci-
ences Corp., Piscataway, NJ, USA) in blocking
solution  for  one  hour  at  room  temperature.
After  washing,  the  blot  was  visualized  with
enhanced  chemiluminescent  detection  kit
(Vector)  and  exposed  to  X-ray  films  (Agfa-
Gevaert N.V., Belgium). Densitometric evalua-
tion of reactive protein bands was performed
using Scion imaging software. The membrane
was washed by stripping buffer, then β-tubulin
(T-4026,  Sigma  Aldrich  co.,  St.  Louis,  MO,
USA) used as an internal control.   
Results 
Clinical study showed that SOD1G93A mice (Tg
mice)  revealed  foot  tremor  from  about  15
weeks of age and the rotarod score significant-
ly  decreased  at  18  (*p<0.05)  and  19
(**p<0.01) weeks of age, and died around 20
weeks  (Figure  1).  Histological  findings  of
soleus muscles with HE staining showed that
neurogenic muscular fiber atrophy was already
present at ten weeks of age and became severe
with time from 15 and 20 weeks in Tg mice
(Figure 2, lower panels).  
As a presynaptic or postsynaptic marker of
NMJ, anti-SV2 antibody and α-BuTX were cho-
sen in this study, which detects synaptic vesi-
cles of axon terminals and AChR of muscles,
respectively. As a marker of synaptic cleft, anti-
agrin antibody was chosen in this study, which
detects anchoring proteins of NMJs. We esti-
mated  functional  NMJs  with  double  positive
for both pre- and postsynaptic markers (Figure
3A). The percentages of double positive NMJs
among α-BuTX single positive were not signif-
icantly different between WT and Tg mice at
five weeks (82.2±9.3% and 67.2±16.0% respec-
tively),  which  then  decreased  in  Tg  mice
through the time from ten weeks (62.5±13.8%
at  ten  weeks,  28.7±8.8%  at  15  weeks,
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Figure  1.  Clinical  scores  of
rotarod tests. Note the decrease
of the score after 15 weeks in
Tg  mice  (filled  triangles)  as
compared  to  wild-type  (open
squares) (*p<0.05, **p<0.01).   
Figure 2. HE staining of soleus muscles in wild-type (WT) and Tg mice. Note a subtle
change in 10 weeks of Tg mice, with deteriorating 15-20 weeks of age.
Figure  3.  Double
immuno-histochemistry
of  anti-SV2  antibody
(green) and α-BuTX (red)
in soleus muscles in wild-
type  (WT)  and Tg  mice.
(A)  Note  the  decrease  of
double  positive  NMJs
from ten weeks in Tg (A,
lower panels), and (B) the
progressive decrease of the
percentages of double pos-
itive  NMJs  in  Tg  mice
(filled triangles) from ten
weeks compared with WT
mice  (open  squares).
(*p<0.05, **p<0.01).13.9±10.4% at 20 weeks) (Figure 3B, filled tri-
angles).  The  number  of  postsynaptic  AChR
clusters did not decrease in Tg mice even at
the end stage (20 weeks). Immunohistoche-
mistry  of  α-BuTX  and  anti-agrin  antibody
revealed  that  there  was  no  increase  of  the
expression levels of agrin throughout the time
course  in  the  control  muscle,  and  the
immunopositive  area  of  anti-agrin  antibody
almost co-localized with the immunopositive
area  of  α-BuTX.  However,  we  found  the
increase of immunopositive area of anti-agrin
antibody around the muscle fiber in Tg mice
from ten weeks of age. (Figure 4A). In Western
blot analysis, the intensity level of α-BuTX did
not significantly differ between wild-type and
Tg mice throughout 5-20 weeks of age (Figure
4B and C).   
Discussion 
In this study, we revealed that the detach-
ment of nerve terminals started at ten weeks,
which is still asymptomatic stage of the disease
course in Tg mice. At ten weeks of age, Tg mice
looked normal and showed the same scores as
wild-type mice in rotarod test, thus histological
abnormality  in  soleus  muscles  preceded  the
clinical signs. Muscle fiber changes also start-
ed at ten weeks in Tg mice. Muscle atrophy pro-
gressed with age (Figure 2) along with the loss
of  functional  NMJs  before  motor  neurons
remained in the spinal cord. These data sug-
gest that a part of spinal motor neurons may
lose  their  function  with  territorial  muscle
fibers even though the neurons showed normal
morphologies. With close analysis of NMJ pro-
teins, the SV2 that is the presynaptic marker of
the NMJs decreased with disease progression
(Figure 3). Decrease of the SV2 starts at ten
weeks of age, indicating that nerve terminals
detach from NMJs from the time of ten weeks
of age of Tg mice. Agrin is a large extracellular
matrix  proteoglycan,  which  potentiates  the
clustering  AChR  by  interacting  with  several
postsynaptic molecules, such as dystroglycan,
integrins, and muscle-specific tyrosine kinase
(MuSK) and organizes the postsynaptic differ-
entiation.
19 There are alternative splicing iso-
forms of agrin, derived from motoneurons or
muscles.
20 The immunoreactivities of agrin in
the muscle spaces developed stronger with the
disease  progression  of  Tg  mice  (Figure  4).
Muscle agrin plays an important role in pre-
serving the transverse orientation in denervat-
ed muscles, though neural agrin more actively
aggregates the AChR.
21 To our surprise, agrin
expression at NMJs did not decrease in atroph-
ic  muscles  in  Tg  mice,  but  increased  at  20
weeks of age (Figure 4B). Because the present
antibody recognized both nerve- and muscle-
derived agrins, the expression levels of muscle
agrin may increase during the disease progres-
sion in Tg mice. The levels of AChR did not
change throughout 5-20 weeks of age in both
groups of mice, and AChR remains clustering
at NMJs (Figure 4), suggesting that the muscle
abnormality  is  the  result  of  detachment  of
nerve terminals. 
A previous report showed that an axotomy
resulted in the nerve terminal degeneration,
where AChR remained clustering at the origi-
nal sites.
15 Subsequently, regenerating axons
differentiated into nerve terminals when they
contacted original synaptic basal lamina.
15 The
detachment characteristics in the current Tg
mice were similar to such a distal axonopa-
thy,
14,15 but the regeneration and the recompo-
sition of the functional NMJs never happened
in the current Tg mice. This difference may be
profoundly related to the pathogenesis of this
ALS model mice, which could be explained by
the defect of axonal transport in Tg mice.
10
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